Oliver E. Brown

854 total citations
22 papers, 748 citations indexed

About

Oliver E. Brown is a scholar working on Molecular Biology, Oncology and Organic Chemistry. According to data from OpenAlex, Oliver E. Brown has authored 22 papers receiving a total of 748 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 8 papers in Oncology and 4 papers in Organic Chemistry. Recurrent topics in Oliver E. Brown's work include DNA and Nucleic Acid Chemistry (5 papers), Biochemical and Molecular Research (4 papers) and Synthesis and Characterization of Heterocyclic Compounds (3 papers). Oliver E. Brown is often cited by papers focused on DNA and Nucleic Acid Chemistry (5 papers), Biochemical and Molecular Research (4 papers) and Synthesis and Characterization of Heterocyclic Compounds (3 papers). Oliver E. Brown collaborates with scholars based in United States, United Kingdom and Netherlands. Oliver E. Brown's co-authors include John László, Earl F. Baril, W. David Sedwick, Kenneth S. McCarty, Harold P. Morris, Pedro M. Fernández‐Salguero, Frank J. Gonzalez, Andrea Sapone, Xiaoxiong Wei and Barry W. Glickman and has published in prestigious journals such as Science, Proceedings of the National Academy of Sciences and JNCI Journal of the National Cancer Institute.

In The Last Decade

Oliver E. Brown

22 papers receiving 653 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Oliver E. Brown United States 11 545 243 104 78 56 22 748
Dean Tsao United States 13 418 0.8× 188 0.8× 85 0.8× 96 1.2× 56 1.0× 22 746
G.P. Margison United Kingdom 19 992 1.8× 178 0.7× 470 4.5× 122 1.6× 61 1.1× 39 1.2k
Shunji Izuta Japan 15 476 0.9× 149 0.6× 85 0.8× 42 0.5× 45 0.8× 29 726
B. K. Sathyanarayana United States 11 472 0.9× 121 0.5× 81 0.8× 62 0.8× 26 0.5× 17 692
Glenn A. Fischer United States 16 914 1.7× 263 1.1× 195 1.9× 83 1.1× 28 0.5× 24 1.3k
Ewa E. Hennig Poland 20 501 0.9× 123 0.5× 184 1.8× 94 1.2× 43 0.8× 50 1.1k
Raymond Gantt United States 18 643 1.2× 112 0.5× 227 2.2× 81 1.0× 25 0.4× 41 862
J Hirata Japan 14 323 0.6× 102 0.4× 79 0.8× 80 1.0× 56 1.0× 28 779
Georgina W. Sikorski United States 8 633 1.2× 408 1.7× 115 1.1× 34 0.4× 18 0.3× 10 800
Y. C. Cheng United States 11 449 0.8× 145 0.6× 38 0.4× 70 0.9× 11 0.2× 14 608

Countries citing papers authored by Oliver E. Brown

Since Specialization
Citations

This map shows the geographic impact of Oliver E. Brown's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Oliver E. Brown with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Oliver E. Brown more than expected).

Fields of papers citing papers by Oliver E. Brown

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Oliver E. Brown. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Oliver E. Brown. The network helps show where Oliver E. Brown may publish in the future.

Co-authorship network of co-authors of Oliver E. Brown

This figure shows the co-authorship network connecting the top 25 collaborators of Oliver E. Brown. A scholar is included among the top collaborators of Oliver E. Brown based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Oliver E. Brown. Oliver E. Brown is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sludden, J, Xiaoxiong Wei, Andrea Sapone, et al.. (1998). Dihydropyrimidine dehydrogenase pharmacogenetics in patients with colorectal cancer. British Journal of Cancer. 77(3). 497–500. 75 indexed citations
2.
Ridge, Susan A., Julieann Sludden, Oliver E. Brown, et al.. (1998). Dihydropyrimidine dehydrogenase pharmacogenetics in Caucasian subjects. British Journal of Clinical Pharmacology. 46(2). 151–156. 105 indexed citations
3.
Brown, Oliver E., et al.. (1997). Mutations at codon 974 of the DPYD gene are a rare event. British Journal of Cancer. 75(2). 178–179. 7 indexed citations
4.
Richards, Randall G., Oliver E. Brown, Maura L. Gillison, & W. David Sedwick. (1986). Drug concentration-dependent DNA lesions are induced by the lipid-soluble antifolate, piritrexim (BW301U).. Molecular Pharmacology. 30(6). 651–658. 4 indexed citations
5.
Sedwick, W. David, Oliver E. Brown, & Barry W. Glickman. (1986). Deoxyuridine misincorporation causes site-specific mutational lesions in the lacI gene of Escherichia coli. Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis. 162(1). 7–20. 33 indexed citations
6.
Richards, Randall G., Oliver E. Brown, & W. David Sedwick. (1985). Misincorporation of Deoxyuridine in Human Cells: Consequences of Antifolate Exposure. PubMed. 31. 149–162. 4 indexed citations
7.
8.
Sedwick, W. David, et al.. (1981). Human Plasma and Amino Acids as Moderators of Uptake and Metabolic Consequences of Antifolates in WIL-2 and Human Leukemia Cells<xref ref-type="fn" rid="FN2">2</xref>. JNCI Journal of the National Cancer Institute. 66(3). 445–51. 2 indexed citations
9.
László, John, et al.. (1981). Toxicity of Methotrexate and Metoprine in a Dihydrofolate Reductase Gene-Amplified Mouse Cell Line. Molecular Pharmacology. 20(3). 637–643. 4 indexed citations
10.
Sedwick, W. David, et al.. (1981). Antifolate-induced misincorporation of deoxyuridine monophosphate into DNA: inhibition of high molecular weight DNA synthesis in human lymphoblastoid cells.. Proceedings of the National Academy of Sciences. 78(2). 917–921. 83 indexed citations
11.
Sedwick, W. David, et al.. (1979). Deoxyuridine Incorporation as a Useful Measure of Methotrexate and Metoprine Uptake and Metabolic Effectiveness. Molecular Pharmacology. 16(2). 607–613. 10 indexed citations
12.
László, John, et al.. (1978). Comparison of metoprine (DDMP) and etoprine (DDEP) by measuring the inhibition of deoxyuridine incorporation into the DNA of human leukemic cells 1,2,3.. PubMed. 62(3). 341–4. 4 indexed citations
13.
Baril, Earl F., et al.. (1971). Deoxyribonucleic acid polymerase with rat liver ribosomes and smooth membranes. Purification and properties of the enzyme. Biochemistry. 10(11). 1981–1992. 121 indexed citations
14.
Baril, Earl F., Oliver E. Brown, & John László. (1971). Co-fractionation of “nickase” with rat liver DNA polymerase. Biochemical and Biophysical Research Communications. 43(4). 754–759. 10 indexed citations
15.
Baril, Earl F., et al.. (1970). DNA Polymerase Activities Associated with Smooth Membranes and Ribosomes from Rat Liver and Hepatoma Cytoplasm. Science. 169(3940). 87–89. 22 indexed citations
16.
László, John, Donald S. Miller, Oliver E. Brown, & Earl F. Baril. (1970). Rat hepatoma DNA polymerase: Partial analysis of the in vitro DNA product. Biochemical and Biophysical Research Communications. 38(1). 112–118. 2 indexed citations
17.
Ove, Peter, Oliver E. Brown, & John László. (1969). DNase II inhibitor in tissues and urine—pH and salt artifacts. Archives of Biochemistry and Biophysics. 131(2). 652–652. 5 indexed citations
18.
László, John, Oliver E. Brown, Donald S. Miller, & Peter Ove. (1969). Pyrophosphate as a selective inhibitor of macromolecule synthesis in normal and leukemic leukocytes. Biochemical Pharmacology. 18(6). 1381–1387. 1 indexed citations
19.
Ove, Peter, Oliver E. Brown, & John László. (1969). Separation of DNA polymerase from rat liver and hepatomas.. PubMed. 29(8). 1562–7. 21 indexed citations
20.
McCarty, Kenneth S., et al.. (1968). Resolution and fractionation of macromolecules by isokinetic sucrose density gradient sedimentation. Analytical Biochemistry. 24(2). 314–329. 106 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Dean Tsao Breakdown of academic impact, for papers by G.P. Margison Breakdown of academic impact, for papers by Shunji Izuta Breakdown of academic impact, for papers by B. K. Sathyanarayana Breakdown of academic impact, for papers by Glenn A. Fischer Breakdown of academic impact, for papers by Ewa E. Hennig Breakdown of academic impact, for papers by Raymond Gantt Breakdown of academic impact, for papers by J Hirata Breakdown of academic impact, for papers by Georgina W. Sikorski Breakdown of academic impact, for papers by Y. C. Cheng
Rankless by CCL
2026